Linehan W
Ir J Med Sci. 2016; 144(1):144.
PMID: 27518949
DOI: 10.1007/BF02939005.
Svensson L
Pharm Res. 2013; 2(4):156-62.
PMID: 24272805
DOI: 10.1023/A:1016379820412.
Lichterfeld A, Lollgen H
Eur J Clin Pharmacol. 1974; 7(5):347-51.
PMID: 4609138
DOI: 10.1007/BF00558204.
Cooke N, Kerr J, Willey R, Hoare M, GRANT I, Cromptom G
Br Med J. 1974; 2(5913):250-2.
PMID: 4597119
PMC: 1610528.
DOI: 10.1136/bmj.2.5913.250.
Marlin G, Turner P
Br Med J. 1975; 2(5973):715-9.
PMID: 1139193
PMC: 1673959.
DOI: 10.1136/bmj.2.5973.715.
Dose-titration comparison of inhaled salbutamol and oral theophylline in asthma.
Marlin G, Harris M, Klumpp J, Rutland J
Br J Clin Pharmacol. 1979; 8(6):595-7.
PMID: 533582
PMC: 1429905.
DOI: 10.1111/j.1365-2125.1979.tb01052.x.
The acute effects of the administration of rimiterol aerosol in asthmatic children.
BLACKHALL M, Macartney B, ODonnell S
Br J Clin Pharmacol. 1978; 6(1):59-62.
PMID: 27205
PMC: 1429394.
DOI: 10.1111/j.1365-2125.1978.tb01682.x.
Assessment of combined oral theophylline and inhaled beta-adrenoceptor agonist bronchodilator therapy.
Marlin G, Hartnett B, Berend N, Hacket N
Br J Clin Pharmacol. 1978; 5(1):45-50.
PMID: 23134
PMC: 1429216.
DOI: 10.1111/j.1365-2125.1978.tb01596.x.
Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma.
Pinder R, Brogden R, Speight T, Avery G
Drugs. 1977; 14(2):81-104.
PMID: 19226
DOI: 10.2165/00003495-197714020-00001.
Comparative potencies and beta2-adrenoreceptor selectivities of rimiterol and salbutamol aerosols.
Marlin G, Hartnett B, Berend N
Br J Clin Pharmacol. 1977; 4(1):77-9.
PMID: 14660
PMC: 1428978.
DOI: 10.1111/j.1365-2125.1977.tb00671.x.
Comparison of the beta2-adrenoceptor selectivity of rimiterol, salbutamol and isoprenaline by the intravenous route in man.
Marlin G, Turner P
Br J Clin Pharmacol. 1975; 2(1):41-8.
PMID: 10940
PMC: 1402492.
DOI: 10.1111/j.1365-2125.1975.tb00470.x.
